Oxymetholone

Revision as of 17:37, 22 January 2015 by Kiran Singh (talk | contribs)
Jump to navigation Jump to search

Oxymetholone
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Oxymetholone is an anabolic steroid that is FDA approved for the treatment of anaemia. Common adverse reactions include cholestatic jaundice, clitoral enlargement, menstrual irregularities,insomnia, nausea, vomiting, diarrhea, gynecomastia.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indications

Oxymetholone tablets is indicated in the treatment of anemias caused by deficient red cell production. Acquired aplastic anemia, congenital aplastic anemia, myelofibrosis and the hypoplastic anemias due to the administration of myelotoxic drugs often respond. Anadrol®-50 Tablets should not replace other supportive measures such as transfusion, correction of iron, folic acid, vitamin B12 or pyridoxine deficiency, antibacterial therapy and the appropriate use of corticosteroids.

Dosage

The recommended daily dose in adults is 1-5 mg/kg of body weight per day. The usual effective dose is 1-2 mg/kg/day but higher doses may be required, and the dose should be individualized. Response is not often immediate, and a minimum trial of three to six months should be given. Following remission, some patients may be maintained without the drug; others may be maintained on an established lower daily dosage. A continued maintenance dose is usually necessary in patients with congenital aplastic anemia.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Oxymetholone in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Oxymetholone in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Indications

Oxymetholone tablets is indicated in the treatment of anemias caused by deficient red cell production. Acquired aplastic anemia, congenital aplastic anemia, myelofibrosis and the hypoplastic anemias due to the administration of myelotoxic drugs often respond. Anadrol®-50 Tablets should not replace other supportive measures such as transfusion, correction of iron, folic acid, vitamin B12 or pyridoxine deficiency, antibacterial therapy and the appropriate use of corticosteroids.

Dosage

The recommended daily dose in children is 1-5 mg/kg of body weight per day. The usual effective dose is 1-2 mg/kg/day but higher doses may be required, and the dose should be individualized. Response is not often immediate, and a minimum trial of three to six months should be given. Following remission, some patients may be maintained without the drug; others may be maintained on an established lower daily dosage. A continued maintenance dose is usually necessary in patients with congenital aplastic anemia.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Oxymetholone in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Oxymetholone in pediatric patients.

Contraindications

There is limited information regarding Oxymetholone Contraindications in the drug label.

Warnings

There is limited information regarding Oxymetholone Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Oxymetholone in the drug label.

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Oxymetholone in the drug label.

Drug Interactions

There is limited information regarding Oxymetholone Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Pregnancy Category


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Oxymetholone in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Oxymetholone during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Oxymetholone with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Oxymetholone with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Oxymetholone with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Oxymetholone with respect to specific gender populations.

Race

There is no FDA guidance on the use of Oxymetholone with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Oxymetholone in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Oxymetholone in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Oxymetholone in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Oxymetholone in patients who are immunocompromised.

Administration and Monitoring

Administration

  • Oral
  • Intravenous

Monitoring

There is limited information regarding Monitoring of Oxymetholone in the drug label.

  • Description

IV Compatibility

There is limited information regarding IV Compatibility of Oxymetholone in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Oxymetholone in the drug label.

Pharmacology

There is limited information regarding Oxymetholone Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Oxymetholone Mechanism of Action in the drug label.

Structure

There is limited information regarding Oxymetholone Structure in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Oxymetholone in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Oxymetholone in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Oxymetholone in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Oxymetholone in the drug label.

How Supplied

Storage

There is limited information regarding Oxymetholone Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Oxymetholone |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Oxymetholone |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

There is limited information regarding Patient Counseling Information of Oxymetholone in the drug label.

Precautions with Alcohol

  • Alcohol-Oxymetholone interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Oxymetholone Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Oxymetholone Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

{{#subobject:

 |Page Name=Oxymetholone
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject:

 |Label Page=Oxymetholone
 |Label Name=Oxymetholone11.png

}}

{{#subobject:

 |Label Page=Oxymetholone
 |Label Name=Oxymetholone11.png

}}